BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 165303)

  • 1. Antibody to herpes simplex virus type 2-induced nonstructural proteins in women with cervical cancer and in control groups.
    Anzai T; Dreesman GR; Courtney RJ; Adam E; Rawls WE; Benyesh-Melnick M
    J Natl Cancer Inst; 1975 May; 54(5):1051-9. PubMed ID: 165303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on herpes simplex virus and cancer.
    Melnick JL; Courtney RJ; Powell KL; Schaffer PA; Melnick MB; Dreesman GR; Anzai T; Adam E
    Cancer Res; 1976 Feb; 36(2 pt 2):845-56. PubMed ID: 175946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reaction patterns of herpes simplex virus type 1 and type 2 proteins with sera of patients with uterine cervical carcinoma and matched controls.
    Gilman SC; Docherty JJ; Clarke A; Rawls WE
    Cancer Res; 1980 Dec; 40(12):4640-7. PubMed ID: 6254649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody to herpes simplex virus type 2-induced early antigens and its radioimmunoassay with sera of cervical carcinoma patients.
    Ito H; Kurihara S; Nishimura C
    Kitasato Arch Exp Med; 1978 Jun; 51(1-2):1-13. PubMed ID: 225600
    [No Abstract]   [Full Text] [Related]  

  • 5. Measurement of antibodies to herpesvirus types 1 and 2 in human sera by microradioimmunoassay.
    Jankowski MA; Petersen EE; Böcker JF
    Acta Virol; 1977 Sep; 21(5):405-11. PubMed ID: 22235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes simplex virus type-specific antibodies detected by indirect and competition ELISA. Comparison of sera from patients with carcinoma of the uterine cervix, age matched controls and patients with recurrent genital herpes.
    Najem SN; Vestergaard BF; Potter CW
    Acta Pathol Microbiol Immunol Scand B; 1983 Jun; 91(3):205-7. PubMed ID: 6308950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigations concerning the evidence of herpes simplex virus type 2 (HSV-2) antibodies in patients with carcinoma of the cervix (author's transl)].
    Dostal V; Fanta D; Reiss-Gutfreund RJ; Janisch H; Berger R
    Wien Klin Wochenschr; 1977 Mar; 89(6):201-3. PubMed ID: 191994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific non-immunoglobulin G antibodies and cell-mediated response to herpes simplex virus antigens in women with cervical carcinoma.
    Thiry L; Sprecher-Goldberger S; Hannecart-Pokorni E; Gould I; Bossens M
    Cancer Res; 1977 May; 37(5):1301-6. PubMed ID: 192446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes simplex type 2 and cervical cancer: immunological and in situ hybridization studies.
    Simard R; Kessous A; Mansour M; Camonis J; Rawls WE
    Prog Clin Biol Res; 1983; 132D():461-9. PubMed ID: 6314363
    [No Abstract]   [Full Text] [Related]  

  • 10. [Herpes simplex virus type 2 antibodies in the husbans of women with cervical cancer].
    Kunkel M; Oberender H; Rätz KH; Hofmann R; Gärtner L; Heise H
    Z Gesamte Hyg; 1979 Aug; 25(8):597-9. PubMed ID: 228506
    [No Abstract]   [Full Text] [Related]  

  • 11. Reactions of immune sera against the nucleocapsid, envelope and whole herpes simplex virus type 1.
    Lesso J; Hána L; Matis J
    Acta Virol; 1976 Feb; 20(1):48-52. PubMed ID: 7940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of herpes simplex virus type-2 antigen(s) in biopsies from carcinoma of the uterine cervix.
    Thankamani V; Kumari TV; Vasudevan DM
    J Exp Pathol; 1985; 2(2):123-33. PubMed ID: 2431113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neutralizing antibodies against type 2 herpes simplex virus in women with cervicouterine cancer].
    Ruiz-Gómez J; Gallegos Vargas G; Carranza García J; Alvarez y Muñoz MT
    Ginecol Obstet Mex; 1977 Dec; 42(254):369-75. PubMed ID: 233828
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunoenzymatic detection of IgA and IgG antibodies to HSV-1, HSV-2 in sera of patients with cervical cancer (author's transl)].
    Fan J; Zeng Y; Liu YF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1982 Feb; 4(1):50-2. PubMed ID: 6279319
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunoprecipitation of herpes simplex virus polypeptides with human sera is related to their ELISA titre.
    Murányiová M; Rajcáni J; Krivjanská M; Matis J; Pogády J
    Acta Virol; 1991 May; 35(3):252-9. PubMed ID: 1683131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Humoral antibodies to the antigens related to the structural protein antigens of the mammary cancer virus (MTV) in breast cancer patients and in healthy donors].
    Litvinov SV; Remennik IV; Kriukova IN
    Biull Eksp Biol Med; 1984 May; 97(5):600-3. PubMed ID: 6326892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of the relationship between genital herpes and carcinoma of the uterine cervix. I. Seroepidemiology of herpes simplex virus type 1 and type 2 in women with a previous history of clinically diagnosed genital herpes.
    Vestergaard BF
    Dev Biol Stand; 1982; 52():95-8. PubMed ID: 6299863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes simplex virus. An expanding relationship to human cancer.
    Smith JW
    J Reprod Med; 1983 Feb; 28(2):116-22. PubMed ID: 6300393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of herpes simplex virus in cervical and vulvar cancer.
    Melnick JL; Dreesman GR; Adam E; Kaufman R
    Dev Biol Stand; 1982; 52():87-94. PubMed ID: 6299862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neutralizing antibodies to herpesvirus type 2 in the blood of women with genital cancer].
    Andonov P; Dundarov S; Iurkov K; Karag'ozov I
    Vopr Onkol; 1972; 18(4):54-8. PubMed ID: 4337597
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.